Discover the Science of Health
Researchers at Wake Forest Baptist Medical Center are embarking on a project to print small human organs. The “body-on-a-chip” project will use 3-D printing—or bioprinting—technology to create mini human-organ systems to test the body’s response to drugs.
Inhaled corticosteroids are used by millions of asthma patients every day. However, as with all treatments to control asthma, there is marked patient-to-patient variability in the response to treatment. New research published today in the New England Journal of Medicine (NEJM) has identified a genetic variant associated with the response to inhaled corticosteroids [1]. Investigators have found that asthma patients who have two copies of a specific gene variant responded only one-third as well to steroid inhalers as those with two copies of the regular gene.
